OP2 Drugs SAS – new member

1 September 2021
New member

OP2 Drugs SAS OP2 Drugs SAS is a biotech company that aims at developing innovative life-saving drugs for unmet medical needs, especially in the cardiology field. Our first patented compound, OP2113, which targets mitochondrial dysfunction, is in preclinical stage, with a strong scientific rational. To know more